NextPlat (NXPL) Q4 2025 earnings summary

Executive summary

• Achieved a significant operational turnaround in late 2025, completing most business improvement plans aimed at cost reduction and profitability in 2026.

• Achieved $54.3 million in revenue for 2025, down 18% year-over-year, reflecting a strategic business turnaround and cost-cutting initiatives.

• Operational profitability improved in Q4 2025, with sequential margin expansion and significant cost reductions.

• Expanded healthcare operations from Florida to nationwide, leveraging a new partnership with HealthWarehouse to support customers in all 50 states.

• Implemented a reverse stock split to maintain Nasdaq listing, emphasizing strong capitalization, no debt, and high insider ownership.

Financial highlights

• Reported 2025 total revenue of $54.3 million, down 18% year-over-year from $66 million, mainly due to lower healthcare segment contributions.

• Healthcare operations revenue was $39.7 million in 2025, down from $52.3 million in 2024; e-commerce revenue grew to $14.6 million.

• Consolidated gross margin for 2025 was 20%, down from 26% in 2024, with sequential improvement noted late in Q4.

• Operating expenses decreased by 50% to $19.9 million, reflecting a $13.7 million non-recurring impairment loss in 2024 and ongoing cost reductions.

• Ended 2025 with $13.7 million in cash, no meaningful debt, and $15 million in working capital.

Outlook and guidance

• Expect continued growth in 340B contract revenue and fulfillment services, with margin improvements throughout 2026.

• Anticipate further reductions in operating losses and improved cash flows as cost discipline continues.

• Positioned for significant business growth and improved profitability in 2026, supported by a strong financial foundation and investments in business development and healthcare operations.

• Management expects further meaningful reductions in operating expenses throughout 2026.

• Plan to provide Q1 2026 performance update after financial close.